PT - JOURNAL ARTICLE AU - Amann, Julia AU - Sleigh, Joanna AU - Vayena, Effy TI - Digital contact-tracing during the Covid-19 pandemic: an analysis of newspaper coverage in Germany, Austria, and Switzerland AID - 10.1101/2020.10.22.20216788 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.22.20216788 4099 - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20216788.short 4100 - http://medrxiv.org/content/early/2020/10/26/2020.10.22.20216788.full AB - Governments around the globe have started to develop and deploy digital contact tracing apps to gain control over the spread of the novel coronavirus (Covid-19). The appropriateness and usefulness of these technologies as a containment measure have since sparked political and academic discussions globally. The present paper contributes to this debate through an exploration of how the national daily newspapers in Germany, Austria, and Switzerland reported on the development and adoption of digital contact-tracing apps during early and after stages of the lockdown. These countries were among the first in Europe to develop apps and were critical voices in the debate of decentralized vs. centralized data processing. We conducted thematic analysis on news coverage published between January and May 2020 in high-circulation national daily newspapers (print) from Germany, Austria, and Switzerland. A total of 148 newspaper articles were included in the final analysis. From our analysis emerged six core themes of the development and adoption of digital contact tracing apps: 1) data governance; 2) role of IT giants; 3) scientific rigor; 4) voluntariness; 5) functional efficacy; 6) role of the app. These results shed light on the different facets of discussion regarding digital contact tracing as portrayed in German-speaking media. As news coverage can serve as a proxy for public perception, this study complements emerging survey data on public perceptions of digital contact tracing apps by identifying potential issues of public concern.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research did not require approval by an ethics committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRelevant data (translated text excerpts from news paper articles) are presented within the manuscript. The full data set (newspaper articles) cannot be shared due to copyright restrictions from the respective publishers.